Publikationen von Welslau, Manfred

Hecht, Markus , Hahn, Dennis, Wolber, Philipp, Hautmann, Matthias G., Reichert, Dietmar, Weniger, Steffi, Belka, Claus, Bergmann, Tobias, Göhler, Thomas, Welslau, Manfred, Große-Thie, Christina, Guntinas-Lichius, Orlando , von der Grün, Jens , Balermpas, Panagiotis , Orlowski, Katrin, Messinger, Diethelm, Stenzel, Karsten G. und Fietkau, Rainer (2021) A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. Cancers 13 (14), S. 3413. Volltext nicht vorhanden.

Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva, Acker, Fabian, Fuhrmann, Stephan, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caillé, Léandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter und Dietrich, Sascha (2021) Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood Advances 5 (13), S. 2707-2716. Volltext nicht vorhanden.

Hecht, Markus , Hahn, Dennis, Wolber, Philipp, Hautmann, Matthias G., Reichert, Dietmar, Weniger, Steffi, Belka, Claus, Bergmann, Tobias, Göhler, Thomas, Welslau, Manfred, Große-Thie, Christina, Guntinas-Lichius, Orlando, von der Grün, Jens, Balermpas, Panagiotis , Orlowski, Katrin, Messinger, Diethelm, Stenzel, Karsten G. und Fietkau, Rainer (2020) Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC Cancer 20 (1). Volltext nicht vorhanden.

Al-Batran, Salah-Eddin, Pauligk, Claudia, Hofheinz, Ralf, Lorenzen, Sylvie, Wicki, Andreas, Siebenhuener, Alexander Rheinhard, Schenk, Michael, Welslau, Manfred, Heuer, Vera, Goekkurt, Eray, Schmalenberg, Harald, Thuss-Patience, Peter C., Waberer, Lisa, Talbot, Jonathan, Goetze, Thorsten Oliver und Homann, Nils (2019) Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK. Journal of Clinical Oncology 37 (15_sup), TPS4142-TPS4142. Volltext nicht vorhanden.